CBD itself is not FDA approved as a supplement, food ingredient, or general wellness product. The FDA has approved exactly one CBD medication, a prescription oral solution called Epidiolex, for treating specific types of seizures. Everything else on the market, including CBD oils, gummies, capsules, and topicals, exists in a regulatory gray zone without FDA approval or oversight.
The One FDA-Approved CBD Product
Epidiolex is a pharmaceutical-grade cannabidiol oral solution approved for treating seizures associated with two rare and severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. It’s approved for patients 2 years of age and older and is available only by prescription. This makes it the only cannabis-derived drug product the FDA has ever approved.
It’s worth noting the FDA has also approved three synthetic cannabis-related drugs, but none of them contain CBD. Marinol and Syndros both contain a lab-made version of THC and are used for chemotherapy-related nausea and appetite loss in AIDS patients. Cesamet contains a compound chemically similar to THC and is also prescribed for chemotherapy nausea. These are sometimes confused with CBD products, but they work through entirely different mechanisms.
Why Other CBD Products Aren’t Approved
The CBD products you see in stores and online, including tinctures, gummies, vape cartridges, and creams, have not gone through the FDA’s drug approval process. They haven’t been evaluated for safety, effectiveness, or quality. The FDA does not currently allow CBD to be legally marketed as a dietary supplement or added to food, either.
In January 2023, the FDA formally stated that its existing regulatory frameworks for foods and supplements “are not appropriate for cannabidiol.” The agency concluded that a new regulatory pathway is needed, one that balances consumer access with safety oversight, and said it would work with Congress to create it. As of now, that new framework doesn’t exist, leaving CBD products in a largely unregulated space.
Health Claims on CBD Products Are Illegal
Despite what labels and websites suggest, companies are not allowed to market CBD products with claims about treating, curing, or preventing diseases. The FDA has repeatedly issued warning letters to companies making unauthorized health claims. An analysis of FDA warning letters from 2015 to 2019 found that 87% of the companies cited were making claims about cancer, and 59% were making claims about Alzheimer’s disease. In total, companies promoted CBD for more than 125 unique health conditions without any evidence meeting the FDA’s standards.
If a CBD product claims to treat a specific medical condition, that’s a red flag. Only Epidiolex, the prescription medication, has the clinical evidence to back up its claims for seizure treatment.
Safety Risks the FDA Has Identified
One reason the FDA hasn’t simply folded CBD into existing supplement regulations is the safety profile. A randomized trial conducted by FDA investigators found that even at commonly reported consumer doses (up to 25 mg per kilogram of body weight per day), CBD caused measurable liver stress. About 5.6% of participants who took CBD experienced liver enzyme elevations more than three times the normal upper limit after just four weeks. Nearly 5% met the criteria for possible drug-induced liver injury. These elevations were dose-dependent and typically appeared within two weeks.
Notably, the study participants were healthy adults not taking any other medications. In real life, many people using CBD also take prescription drugs, which could amplify the risk. Animal studies have also raised concerns about effects on the male reproductive system, including damage to sperm production, though human data on this remains limited.
Quality Problems in Unregulated Products
Without FDA oversight, the quality of CBD products varies enormously. A study analyzing 202 commercially available CBD products in the United States found contamination across every product category tested: tinctures, gummies, vape products, and topicals.
- Heavy metals: Detected in 44 of 202 products, with lead being the most common.
- Residual solvents: Found in 181 of 202 products, including hexane and methanol.
- Pesticides: 26 different pesticides were detected across 30 products.
- Unexpected THC: Three products labeled as “broad-spectrum” (meaning THC-free) actually contained THC, with two exceeding the legal 0.3% limit.
While most contamination levels fell below established safety thresholds, the sheer prevalence of contaminants highlights the gap between what consumers expect and what they’re actually getting. There’s no FDA-mandated testing, labeling accuracy requirement, or manufacturing standard for these products.
Hemp Seed Products Are Different
One common point of confusion: hemp seed oil, hemp seed protein, and hemp seed powder are not the same as CBD. These ingredients come from the seeds of the hemp plant and contain little to no CBD. They have a separate regulatory status and can be legally used in food products. If you see “hemp seed oil” on a label, that product is not a CBD product, even though both come from the cannabis plant.